488 related articles for article (PubMed ID: 30767591)
1. Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?
Marasini N; Kaminskas LM
Drug Dev Ind Pharm; 2019 Jun; 45(6):882-894. PubMed ID: 30767591
[TBL] [Abstract][Full Text] [Related]
2. Nasal and pulmonary vaccine delivery using particulate carriers.
Jia Y; Krishnan L; Omri A
Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
[TBL] [Abstract][Full Text] [Related]
3. Subunit vaccines of the future: the need for safe, customized and optimized particulate delivery systems.
Foged C
Ther Deliv; 2011 Aug; 2(8):1057-77. PubMed ID: 22826868
[TBL] [Abstract][Full Text] [Related]
4. Thermostable Subunit Vaccines for Pulmonary Delivery: How Close Are We?
Foged C
Curr Pharm Des; 2016; 22(17):2561-76. PubMed ID: 26831645
[TBL] [Abstract][Full Text] [Related]
5. Dry powder vaccines for mucosal administration: critical factors in manufacture and delivery.
Wang SH; Thompson AL; Hickey AJ; Staats HF
Curr Top Microbiol Immunol; 2012; 354():121-56. PubMed ID: 21822816
[TBL] [Abstract][Full Text] [Related]
6. Particulate vaccines: on the quest for optimal delivery and immune response.
De Temmerman ML; Rejman J; Demeester J; Irvine DJ; Gander B; De Smedt SC
Drug Discov Today; 2011 Jul; 16(13-14):569-82. PubMed ID: 21570475
[TBL] [Abstract][Full Text] [Related]
7. Intranasal formulations: promising strategy to deliver vaccines.
Riese P; Sakthivel P; Trittel S; Guzmán CA
Expert Opin Drug Deliv; 2014 Oct; 11(10):1619-34. PubMed ID: 24962722
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticulate Carriers Used as Vaccine Adjuvant Delivery Systems.
Wang N; Qian R; Liu T; Wu T; Wang T
Crit Rev Ther Drug Carrier Syst; 2019; 36(5):449-484. PubMed ID: 32421952
[TBL] [Abstract][Full Text] [Related]
9. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
De Magistris MT
Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
[TBL] [Abstract][Full Text] [Related]
10. Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery.
Gause KT; Wheatley AK; Cui J; Yan Y; Kent SJ; Caruso F
ACS Nano; 2017 Jan; 11(1):54-68. PubMed ID: 28075558
[TBL] [Abstract][Full Text] [Related]
11. Mucosal adjuvants and delivery systems for protein-, DNA- and RNA-based vaccines.
Vajdy M; Srivastava I; Polo J; Donnelly J; O'Hagan D; Singh M
Immunol Cell Biol; 2004 Dec; 82(6):617-27. PubMed ID: 15550120
[TBL] [Abstract][Full Text] [Related]
12. Adjuvants and delivery systems based on polymeric nanoparticles for mucosal vaccines.
Jin Z; Gao S; Cui X; Sun D; Zhao K
Int J Pharm; 2019 Dec; 572():118731. PubMed ID: 31669213
[TBL] [Abstract][Full Text] [Related]
13. New developments in dry powder pulmonary vaccine delivery.
Sou T; Meeusen EN; de Veer M; Morton DA; Kaminskas LM; McIntosh MP
Trends Biotechnol; 2011 Apr; 29(4):191-8. PubMed ID: 21255854
[TBL] [Abstract][Full Text] [Related]
14. Synthetic biomimetic supra molecular Biovector (SMBV) particles for nasal vaccine delivery.
von Hoegen P
Adv Drug Deliv Rev; 2001 Sep; 51(1-3):113-25. PubMed ID: 11516783
[TBL] [Abstract][Full Text] [Related]
15. PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.
Silva AL; Soema PC; Slütter B; Ossendorp F; Jiskoot W
Hum Vaccin Immunother; 2016 Apr; 12(4):1056-69. PubMed ID: 26752261
[TBL] [Abstract][Full Text] [Related]
16. PLGA particulate subunit tuberculosis vaccines promote humoral and Th17 responses but do not enhance control of Mycobacterium tuberculosis infection.
Ashhurst AS; Parumasivam T; Chan JGY; Lin LCW; Flórido M; West NP; Chan HK; Britton WJ
PLoS One; 2018; 13(3):e0194620. PubMed ID: 29554138
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
[TBL] [Abstract][Full Text] [Related]
18. Mucosal vaccine delivery: Current state and a pediatric perspective.
Shakya AK; Chowdhury MYE; Tao W; Gill HS
J Control Release; 2016 Oct; 240():394-413. PubMed ID: 26860287
[TBL] [Abstract][Full Text] [Related]
19. [Nasal vaccines].
Kido H; Mizuno D; Takei T
Nihon Rinsho; 2008 Oct; 66(10):1881-7. PubMed ID: 18939485
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary vaccine delivery.
Lu D; Hickey AJ
Expert Rev Vaccines; 2007 Apr; 6(2):213-26. PubMed ID: 17408371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
